News from disc medicine A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 13, 2021, 16:30 ET Disc Medicine Appoints William White to its Board of Directors

Disc Medicine, a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating...

Dec 02, 2020, 18:00 ET Disc Medicine to Present at the Virtual 62nd American Society of Hematology Annual Meeting

Disc Medicine, a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating...

Nov 23, 2020, 10:00 ET Disc Medicine to Present at the Piper Sandler 32nd Annual Healthcare Conference

Disc Medicine, a hematology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating diseases, ...

Oct 13, 2020, 16:00 ET Disc Medicine Expands Scientific Advisory Board with Leading Experts in Hepcidin Biology

Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic...

Sep 08, 2020, 07:00 ET Disc Medicine to Present at Citi's 15th Annual BioPharma Virtual Conference

Disc Medicine, a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating...

Aug 03, 2020, 07:00 ET Disc Medicine Expands Leadership Team with Industry Veterans to Advance Hepcidin Modulating Therapies Toward the Clinic

Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic...

Jan 28, 2020, 07:00 ET John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer

Disc Medicine, a hematology company applying new insights in hepcidin biology to develop therapies that restore red blood cell production in...

Oct 29, 2019, 07:00 ET Disc Medicine Expands Pipeline Focused on Hepcidin Pathway

Disc Medicine, a hematology company that is applying new insights in hepcidin biology to develop therapies addressing ineffective red blood cell...

Oct 29, 2019, 07:00 ET Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production

Disc Medicine, a hematology company applying new insights in hepcidin biology to develop therapies that restore red blood cell production in...